All systems operational
For Researchers For Publishers Login Register
Home Publications Journal of the Egyptian National Cancer Institute
Q1 2018

Expression of truncated HER2 and its prognostic value in HER2-positive breast cancer patients

Alaa Mohamed Maria · Mohamed El-Shebiney · Ayman Mohamed El-Saka · Yomna Zamzam
10.1016/j.jnci.2018.05.001 379 Views 11 Citations
11
Citations
379
Views
Abstract not available for this publication.
Cite this Article (APA)
Alaa, M. M., Mohamed, E., Ayman, M. E., Yomna, Z. (2018). Expression of truncated HER2 and its prognostic value in HER2-positive breast cancer patients. Journal of the Egyptian National Cancer Institute. https://doi.org/10.1016/j.jnci.2018.05.001
Related Papers
Management of glioblastoma after recurrence: A changing paradigm
Supriya Mallick; Rony Benson; Abdul Hakim; Goura K. Rath · 2016
104
cites
393
Management of glioblastoma after recurrence: A changing paradigm
Supriya Mallick; Rony Benson; Abdul Hakim; Goura K. Rath · 2016
104
cites
390
Radiation induced liver disease: A clinical update
R. Benson; R. Madan; R. Kilambi; S. Chander · 2016
102
cites
391
Radiation induced liver disease: A clinical update
R. Benson; R. Madan; R. Kilambi; S. Chander · 2016
102
cites
385
Radiation induced heart disease: Pathogenesis, management and review literature
R. Madan; R. Benson; D.N. Sharma; P.K. Julka; G.K. Rath · 2015
96
cites
389
Access
View Full Text via DOI
Published in
ISSN 1110-0362
Quartile Q1
AMS Score 94
Field Medicine & Health Sciences
Publisher Springer Nature / National Cancer I
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2018
Language English
Added 24 Aug 2026